文献速递性腺与生殖内分泌垂体与肾上腺疾病

艾迪生病女性的原发性卵巢功能不全研究

Primary Ovarian Insufficiency in Women With Addison's Disease.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

基于挪威国家艾迪生病登记处的观察性队列研究纳入461例自身免疫性艾迪生病(AAD)女性,发现原发性卵巢功能不全(POI)患病率为10.2%(47/461),其中三分之一在30岁前发生POI。超过半数POI先于或与AAD诊断同时出现,合并自身免疫病者占72%,AAD伴POI者自身抗体更多(≥2种自身抗体78% vs 25%)。抗侧链裂解酶(SCC)抗体对POI阴性预测值达96%,激素替代治疗(HRT)使用率高于年龄匹配正常人群(11.3% vs 0.7%)。

要点

  • AAD女性中约十分之一患POI,需关注卵巢功能。
  • 抗SCC抗体对POI阴性预测值达96%,可作为筛查指标。
  • 建议AAD女性<40岁有月经异常或生育问题检测抗SCC抗体。

核心结论

  • 每10例AAD女性中约1例患POI。
  • 抗SCC抗体是自身免疫性POI最特异的标志物。
  • 建议AAD女性<40岁伴月经紊乱或生育顾虑者检测抗SCC抗体。

研究设计与样本

  • 基于挪威国家艾迪生病登记处的观察性人群队列研究。
  • 纳入461例AAD女性,使用挪威处方数据库评估HRT处方。
  • 主要结局为POI患病率,次要结局包括临床特征、自身抗体和全基因组SNP变异。

主要发现

  • POI患病率为10.2%(47/461),其中三分之一在30岁前发生POI。
  • 超过半数POI先于或与AAD诊断同时出现。
  • 合并自身免疫病者占72%,AAD伴POI者≥2种自身抗体比例78% vs 无POI者25%。
  • 抗SCC抗体对POI的阴性预测值为96%。
  • HRT使用率高于年龄匹配正常人群(11.3% vs 0.7%)。

关键数值与推荐

  • POI定义为40岁前绝经。
  • 抗SCC抗体对POI阴性预测值96%。
  • AAD伴POI者≥2种自身抗体比例78%,无POI者25%。
  • HRT使用率11.3% vs 年龄匹配正常人群0.7%。

临床怎么用

  • 对AAD女性<40岁伴月经紊乱或生育顾虑者检测抗SCC抗体。
  • 关注AAD女性POI风险,必要时评估卵巢功能。
  • AAD女性HRT使用率较高,需规范管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Primary ovarian insufficiency (POI) is defined by menopause before 40 years of age. POI prevalence is higher among women with autoimmune Addison's disease (AAD) than in the general population, but their clinical characteristics are insufficiently studied. OBJECTIVE: To assess the prevalence of POI in a large cohort of women with AAD and describe clinical, immunological, and genetic characteristics. METHODS: An observational population-based cohort study of the Norwegian National Addison Registry. The Norwegian Prescription Database was used to assess prescription of menopausal hormone replacement therapy (HRT). A total of 461 women with AAD were studied. The primary outcome measure was prevalence of POI. Secondary outcomes were clinical characteristics, autoantibodies, and genome-wide single nucleotide polymorphism variation. RESULTS: The prevalence of POI was 10.2% (47/461) and one-third developed POI before 30 years of age. POI preceded or coincided with AAD diagnosis in more than half of the women. The prevalence of concomitant autoimmune diseases was 72%, and AAD women with POI had more autoantibodies than AAD women without (≥2 autoantibodies in 78% vs 25%). Autoantibodies against side-chain cleavage enzyme (SCC) had the highest accuracy with a negative predictive value for POI of 96%. HRT use was high compared to the age adjusted normal population (11.3 % vs 0.7%). CONCLUSION: One in 10 women with AAD have POI. Autoantibodies against SCC are the most specific marker for autoimmune POI. We recommend testing women with AAD <40 years with menstrual disturbances or fertility concerns for autoantibodies against SCC.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Vogt EC, Breivik L, Røyrvik EC, et al. Primary Ovarian Insufficiency in Women With Addison's Disease. J Clin Endocrinol Metab. 2021. PMID: 33686417. doi:10.1210/clinem/dgab140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。